1245 Zoledronic acid and Taxotere (ZANTE) metronomic and sequential administration in patients with hormone refractory prostate cancer (HRPC) – final results of phase I study
M. Caraglia, A. Morabito, M. Marra, A.M. Bochicchio, M.C. Piccirillo, R. Franco, F. Perrone, A. Budillon, R.V. Iaffaioli, G. FacchiniVolume:
7
Year:
2009
Language:
english
DOI:
10.1016/s1359-6349(09)70457-4
File:
PDF, 49 KB
english, 2009